Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

U Creutzig

Showing results (21-30 of 158) with videos related to

Pageof 16
Sort By:
Onkologie|April 1, 1986
[Risk groups in acute, non-lymphatic leukemia in childhood. Analysis of the results of the cooperative therapeutic studies AML-BFM 78 and 83]J Ritter, U Creutzig, G Schellong
Klinische Padiatrie|September 3, 1999
[Expert network for pediatric oncology and hematology]U Creutzig, H Jürgens, G Henze
Annals of Hematology|May 6, 2004
Prognostic relevance of risk groups in the pediatric AML-BFM trials 93 and 98U Creutzig, D Reinhardt, M Zimmermann, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 18, 2004
Revised recommendations of the International Working Group for diagnosis, standardization of response criteria, treatment outcomes, and reporting standards for therapeutic trials in acute myeloid leukemiaU Creutzig, G J L Kaspers
Klinische Padiatrie|May 1, 1988
[Therapy realization and complications in the BFM-83 therapy study of acute myelogenous leukemia]U Creutzig, J Hofmann, J Ritter, et al.
Klinische Padiatrie|July 1, 1989
[Incidence and prognostic significance of Auer rods in children with acute myeloid leukemia in the studies AML-BFM-78 and -83]J Vormoor, J Ritter, U Creutzig, et al.
Klinische Padiatrie|July 1, 1983
[Philadelphia chromosome-positive acute lymphoblastic leukemia in childhood: a special risk group?]U Creutzig, J Ritter, G Schellong, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 1993
Does cranial irradiation reduce the risk for bone marrow relapse in acute myelogenous leukemia? Unexpected results of the Childhood Acute Myelogenous Leukemia Study BFM-87U Creutzig, J Ritter, M Zimmermann, et al.
Klinische Padiatrie|July 1, 1996
[Prognosis of children with chronic myeloid leukemia: a retrospective analysis of 75 patients]U Creutzig, J Ritter, M Zimmermann, et al.
Klinische Padiatrie|May 1, 1981
[Acute leukemia in a 13-year old boy with a synchronous occurrence of lympho- and monoblasts (author's transl)]U Creutzig, C Eschenbach, J Ritter, et al.
Pageof 16

Showing results (21-30 of 158) with videos related to

Sort By:
Pageof 16
Onkologie|April 1, 1986
[Risk groups in acute, non-lymphatic leukemia in childhood. Analysis of the results of the cooperative therapeutic studies AML-BFM 78 and 83]J Ritter, U Creutzig, G Schellong
Klinische Padiatrie|September 3, 1999
[Expert network for pediatric oncology and hematology]U Creutzig, H Jürgens, G Henze
Annals of Hematology|May 6, 2004
Prognostic relevance of risk groups in the pediatric AML-BFM trials 93 and 98U Creutzig, D Reinhardt, M Zimmermann, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 18, 2004
Revised recommendations of the International Working Group for diagnosis, standardization of response criteria, treatment outcomes, and reporting standards for therapeutic trials in acute myeloid leukemiaU Creutzig, G J L Kaspers
Klinische Padiatrie|May 1, 1988
[Therapy realization and complications in the BFM-83 therapy study of acute myelogenous leukemia]U Creutzig, J Hofmann, J Ritter, et al.
Klinische Padiatrie|July 1, 1989
[Incidence and prognostic significance of Auer rods in children with acute myeloid leukemia in the studies AML-BFM-78 and -83]J Vormoor, J Ritter, U Creutzig, et al.
Klinische Padiatrie|July 1, 1983
[Philadelphia chromosome-positive acute lymphoblastic leukemia in childhood: a special risk group?]U Creutzig, J Ritter, G Schellong, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 1993
Does cranial irradiation reduce the risk for bone marrow relapse in acute myelogenous leukemia? Unexpected results of the Childhood Acute Myelogenous Leukemia Study BFM-87U Creutzig, J Ritter, M Zimmermann, et al.
Klinische Padiatrie|July 1, 1996
[Prognosis of children with chronic myeloid leukemia: a retrospective analysis of 75 patients]U Creutzig, J Ritter, M Zimmermann, et al.
Klinische Padiatrie|May 1, 1981
[Acute leukemia in a 13-year old boy with a synchronous occurrence of lympho- and monoblasts (author's transl)]U Creutzig, C Eschenbach, J Ritter, et al.
Pageof 16